-
effectivehealthcare-admin.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
June 01, 2013 - The first is identifying and monitoring new and evolving
health care interventions that are purported … The manufacturer has issued warnings against interference from medical monitoring,
diagnostic, or life
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-draft-report.pdf
January 31, 2025 - Common example situation: outcome is
intermediate (modifiable risk factor or indicator) while the review … Situation for this review: data for the exposure and outcome
are provided but the study was not designed
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_disposition-comments.pdf
June 28, 2013 - instance, some studies record only symptomatic atrial fibrillation as an
endpoint; the degree of monitoring … No studies to our knowledge have used 100%
monitoring devices for this endpoint.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - Second, in the
situation of rare diseases, RCTs may have to draw from a very small population of interest
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - Second, in the
situation of rare diseases, RCTs may have to draw from a very small population of interest
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-binary-outcomes-evaluation_research.pdf
March 11, 2013 - This situation is analogous to univariate meta-
analysis, where for non-variance-stabilizing link functions
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_executive.pdf
July 01, 2012 - illness-associated weakness, pneumothorax, delirium,
and infections associated with the invasive monitoring
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
August 01, 2012 - brand
name, reasons included increase in seizure
frequency (19.6% versus 1.6%, p<0.0001); careful
monitoring
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
August 01, 2012 - brand
name, reasons included increase in seizure
frequency (19.6% versus 1.6%, p<0.0001); careful
monitoring
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
September 01, 2008 - new disposition of comments insulin analogues -- jda revs.xls
Comment, by Section Response
Executive Summary
Comment: A statement under Gaps in Evidence and Future Direction…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
May 01, 2013 - 1
Comparative Effectiveness Review
Number 90
Pressure Ulcer Treatment Strategies:
Comparative Effectiveness
Executive Summary
Background
Uninterrupted pressure exerted on the
skin, soft tissue, muscle, and bone can
lead to the development of localized
ischemia, tissue inflammation, shearing,
anoxia, and …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
January 01, 2014 - In this situation, in which double-blinding has
not been feasible, the challenge to execute studies
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
September 25, 2013 - In this section, it
is stated: “studies generally indicated that patients with test-
based monitoring … Use of phenotypic
testing (but not genetic testing) as a monitoring test can be
considered a variation … Note
that the same situation appears in many laboratory tests;
in all these cases the latent variable
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
October 01, 2015 - accuracy, risks,
and patient preferences pose significant challenges in
determining optimal testing and monitoring … Substantial statistical heterogeneity was present in most
pooled analyses of diagnostic accuracy; this situation
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
May 01, 2013 - (Similar situation for 1st trimester BMI).
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - telmisartan and
ramipril in patients with mild-to-moderate
hypertension using ambulatory blood pressure
monitoring … investigation of the safety
and efficacy of telmisartan versus ramipril using
ambulatory blood pressure monitoring … in adults with mild to moderate essential
hypertension, as assessed by ambulatory blood
pressure monitoring
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
January 01, 2014 - diagnostic
sensitivities
and
specificities of
the system for
the diagnosis
and monitoring
of CDI … They concluded
that fidaxomicin appeared to be well-tolerated, but that
continued monitoring of adverse
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
August 01, 2020 - defines the scope of IT to include electronic medical record
interventions such as prescription drug monitoring … e.g., patient-provider
communication, treatment, and/or counseling, educational support, reminders, monitoring … following
intervention implementation.70
Ongoing research is beginning to examine wearables and GPS monitoring
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-patient-family-engagement.pdf
October 01, 2023 - Making Healthcare Safer IV_Rapid Response: Patient and Family Engagement
Making Healthcare Safer IV
Patient and Family Engagement
Rapid Response
Main Points
• Patient and family engagement as a patient safety practice (PSP) is an emerging area with
few studies evaluating the effectiveness of such enga…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
December 01, 2015 - Psychosocial assessment and monitoring in the new era of
non-interferon-alpha hepatitis C virus treatments